Medical Products Supplies Companies

P.O. Box 57506, 6721832 Tel Aviv
Ben Avigdor 8 3rd Floor, 6721832 Tel Aviv
Israel
Telephone +972 3 757595
hello@mobileodt.com

Home

Product Categories

Product categories

01 Electromedical Equipment / Medical Technology
01.01 Diagnostics
01.01.04 Colposcopes, equipment for gynaecological investigation and diagnosis

Colposcopes, equipment for gynaecological investigation and diagnosis

Our products

Product category: Colposcopes, equipment for gynaecological investigation and diagnosis
The EVA System
MobileODT helps clinicians utilize the power of AI through portable medical devices to enhance women’s health. Our Enhanced Visual Assessment (EVA) System is saving lives by enabling early detection for cervical cancer. The CE-marked and FDA-cleared smart mobile colposcope is used by clinicians in over 40 countries and across more than 60 US health systems for colposcopy, general gynecology, tele-colposcopy, and forensic imaging.

As a mobile and affordable colposcope, the EVA System drastically improves accessibility to expert care by enabling remote collaboration and online medical documentation. MobileODT is integrating its Augmented Intelligence (AI) in approved markets to provide powerful clinical decision support to healthcare providers. The AI breakthrough of the Automated Visual Evaluation (AVE) algorithm announced by the US National Cancer Institute in January 2019, will enable healthcare providers to detect cervical cancer and at the point-of-care in less than one second, with a single image of the cervix taken on the EVA System, enabling a ‘screen and treat’ offering to be available worldwide

ad: contact information

About Us

Company details
MobileODT helps clinicians utilize the power of AI through portable medical devices to enhance women’s health. Combining advanced imaging, data and software applications, MobileODT’s Enhanced Visual Assessment (EVA) System is saving lives by enabling early detection for cervical cancer. The CE-marked and FDA-cleared smart mobile colposcope is used by clinicians in over 40 countries and across more than 60 US health systems for colposcopy, general gynecology, tele-colposcopy, and forensic imaging.

As a mobile and affordable colposcope, the EVA System drastically improves accessibility to expert care by enabling remote collaboration and online medical documentation. MobileODT is integrating its Augmented Intelligence (AI) in approved markets to provide powerful clinical decision support to healthcare providers. The AI breakthrough of the Automated Visual Evaluation (AVE) algorithm announced by the US National Cancer Institute in January 2019, will enable healthcare providers to detect cervical cancer and at the point-of-care in less than one second, with a single image of the cervix taken on the EVA System, enabling a ‘screen and treat’ offering to be available worldwide.

Company data
Number of employees

50-99
Area of business

Diagnostics

ad: company